Skip to main content

Table 1 Serum marker assessment in swainsonine-treated mice

From: Hematological and histopathological effects of swainsonine in mouse

  LDH
U/L
ALP
U/L
AST
U/L
ALT
U/L
IBIL
mg/dL
F0-I 783.9 ± 96.2* 269.84 ± 31.58* 184.32 ± 12.5* 65.87 ± 8.57* 0.43 ± 0.03*
F0-II 718.5 ± 95.7* 221.47 ± 32.85* 178.7 ± 10.8* 59.78 ± 9.55* 0.37 ± 0.05*
F0-III 623.8 ± 99.3 193.58 ± 35.87 120.87 ± 11.8 48.47 ± 8.77 0.029 ± 0.02*
F0-IV 587.2 ± 95.8 188.97 ± 27.31 98.11 ± 9.36 41.05 ± 9.58 0.11 ± 0.011
F1-I 547.54 ± 93.25 214.85 ± 7.5 116.58 ± 9.32 47.32 ± 8.50 0.28 ± 0.03*
F1-II 551.87 ± 90.58 218.55 ± 8.1 111.56 ± 9.65 45.36 ± 8.01 0.20 ± 0.01*
F1-III 569.65 ± 85.79 203.51 ± 7.5 105.8 ± 12.21 42.11 ± 7.59 0.18 ± 0.02*
F1-IV 554.88 ± 80.69 198.65 ± 6.8 92.34 ± 8.65 38.25 ± 7.20 0.095 ± 0.02
  1. The values are the mean ± S.D.
  2. *Significantly different from the control group at same generation (P < 0.05).